Health product recall

Votrient: The dissolution is out of specification in the affected lot

Last updated

Summary

Product
Votrient
Issue
Health products - Product quality
What to do

Consult your health care professional if you have any health concerns.

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Votrient Votrient DIN 02352303 Tablet PAZOPANIB (PAZOPANIB HYDROCHLORIDE) 200 MG MJ5389

Issue

The dissolution is out of specification in the affected lot.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Novartis Pharmaceuticals Canada Inc.

100 700 rue St-Hubert, Montréal

Québec H2Y 0C1

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74593